Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India’s SRL Ranbaxy Said Merging With Religare Wellness

This article was originally published in PharmAsia News

Executive Summary

Diagnostics maker SRL Ranbaxy is considering a merger with drug retailer Fortis HealthWorld before it makes an initial public offering, an effort to increase its value, according to an insider. Fortis HealthWorld just recently changed its name to Religare Wellness as part of an earlier rearrangement, and a Religare spokesman said, "there are no merger plans as of today." SRL, owned by Ranbaxy Laboratories, has a chain of pathological laboratories in India, and a merger with Religare would increase its IPO value by tying it with the latter's technology services and outsourcing business. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069370

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel